Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Endostatins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 755 Carboplatin 662 Paclitaxel 616 Bevacizumab 604 pembrolizumab 583 Cisplatin 569 Gemcitabine 513 Docetaxel 485 Radiotherapy 465 Rituximab 464 Dexamethasone 417 Nivolumab 385 Doxorubicin 372 Capecitabine 328 Fluorouracil 325 Etoposide 303 Pemetrexed 280 Oxaliplatin 279 Cytarabine 278 Lenalidomide 270 Prednisone 270 Erlotinib Hydrochloride 260 fludarabine phosphate 260 Leucovorin 251 fludarabine 247 Trastuzumab 246 Bortezomib 239 Vincristine 238 Filgrastim 232 Cetuximab 226

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01218594 2012-10-17

DP-EN-RT

Sun Yat-sen University

Phase 2 Unknown

50 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡